Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 13 USDMF, 7 EU WC, 5 KDMF, 9 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

35 Intermediates Suppliers

35 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 6 FDA Orange Book, 4 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 21 Direct Compression, 18 Solubilizers, 17 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 13 Granulation, 11 Lubricants & Glidants, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 8 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22465 / DOSAGE - TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PAZOPANIB HYDROCHLORIDE(UNII: 33Y9ANM545) (PAZOPANIB - UNII:7RN5DR86CK)	PAZOPANIB	200mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYSORBATE 80(6OZP39ZG8H)
POVIDONES(FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Pazopanib Hydrochloride